Anúncio
Anúncio

BNTX

BNTX logo

BioNTech SE - ADR

96.83
USD
Patrocinado
+0.14
+0.14%
05 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

97.66

+0.84
+0.87%

Relatórios de Lucros BNTX

Rácio de surpresa positiva

BNTX separação 17 de 25 últimas estimativas.

68%

Próximo Relatório

Data do Próximo Relatório
10 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$818.49M
/
-$0.01
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-46.11%
/
-91.67%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-31.22%
/
-100.93%

BioNTech SE - ADR earnings per share and revenue

On 03 de nov. de 2025, BNTX reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 44.42% surprise. Revenue reached 1.52 bilhão, compared to an expected 979.55 milhão, with a 55.06% difference. The market reacted with a +0.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analistas forecast an EPS of -0.01 USD, with revenue projected to reach 818.49 milhão USD, implying an diminuir of -91.67% EPS, and diminuir of -46.11% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
logo
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
For Q3 2025, BioNTech SE - ADR reported EPS of -$0.12, beating estimates by 44.42%, and revenue of $1.52B, 55.06% above expectations.
The stock price moved up 0.04%, changed from $103.91 before the earnings release to $103.95 the day after.
The next earning report is scheduled for 10 de mar. de 2026.
Based on 18 analistas, BioNTech SE - ADR is expected to report EPS of -$0.01 and revenue of $818.49M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio